Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF

Cyclophosphamide, methotrexate and fluorouracil adjuvant combination chemotherapy for breast cancer is currently used for the duration of six monthly courses. We performed a joint analysis of two studies on the duration of adjuvant cyclophosphamide, methotrexate and fluorouracil in patients with nod...

Descripción completa

Detalles Bibliográficos
Autores principales: Colleoni, M, Litman, H J, Castiglione-Gertsch, M, Sauerbrei, W, Gelber, R D, Bonetti, M, Coates, A S, Schumacher, M, Bastert, G, Rudenstam, C-M, Schmoor, C, Lindtner, J, Collins, J, Thürlimann, B, Holmberg, S B, Crivellari, D, Beyerle, C, Neumann, R L A, Goldhirsch, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375405/
https://www.ncbi.nlm.nih.gov/pubmed/12087454
http://dx.doi.org/10.1038/sj.bjc.6600334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375405/
https://www.ncbi.nlm.nih.gov/pubmed/12087454
http://dx.doi.org/10.1038/sj.bjc.6600334

Ejemplares similares